Pacira Cash And Short Term Investments from 2010 to 2024

PCRX Stock  USD 27.63  0.50  1.78%   
Pacira Pharmaceuticals Cash And Short Term Investments yearly trend continues to be fairly stable with very little volatility. Cash And Short Term Investments will likely drop to about 237.8 M in 2024. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
2009-12-31
Previous Quarter
278.6 M
Current Value
325.9 M
Quarterly Volatility
176.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pacira Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 16.1 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Pacira Pharmaceuticals Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.

Latest Pacira Pharmaceuticals' Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Pacira Pharmaceuticals over the last few years. Short Term Investments is an account in the current assets section of Pacira Pharmaceuticals balance sheet. This account contains Pacira Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Pacira Pharmaceuticals fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Pacira Pharmaceuticals' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

Pacira Cash And Short Term Investments Regression Statistics

Arithmetic Mean244,186,811
Geometric Mean170,026,156
Coefficient Of Variation73.28
Mean Deviation136,366,176
Median237,755,169
Standard Deviation178,946,623
Sample Variance32021.9T
Range644M
R-Value0.71
Mean Square Error17222.6T
R-Squared0.50
Significance0
Slope28,310,294
Total Sum of Squares448306.5T

Pacira Cash And Short Term Investments History

2024237.8 M
2023278.6 M
2022288.7 M
2021656.4 M
2020521.7 M
2019291.9 M
2018383.5 M

About Pacira Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Pacira Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Pacira Pharmaceuticals investors use historical funamental indicators, such as Pacira Pharmaceuticals's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Pacira Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Pacira Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pacira Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pacira Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pacira Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Short Term Investments278.6 M237.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pacira Stock Analysis

When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.